Views & Analysis New strategies for stakeholder engagement in life sciences As the influence of a wider range of stakeholders increasingly impacts drug development, what are the best ways to find the right people and start a meaningful dialogue?
Views & Analysis Harmonised health technology assessment in Europe? There's a... Europe is heading towards harmonisation in health technology assessment – but great differences remain in practices and culture
Market Access Row over CF drug funding as NHS rejects Vertex offer Vertex 'astonished and dismayed' by NHS rejection
Views & Analysis Need for leaders as Value & Access plays increasing role in ... Ana Céspedes, senior vice president of global marketing and strategy at EMD Serono, on the evolution of the Value & Access function.
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.